# Boston Scientific Corporation (BSX) — Q1-2025 Earnings Results

**Report date:** 2025-04-23 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q1-2025

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 4.07%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.75 | N/A | +12.28% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's ability to navigate current market conditions. They emphasized a focus on product development and customer needs.

**Key quotes:**

> Management highlighted strong performance in key product segments.

> They noted ongoing investments in innovation to drive future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's strong EPS performance indicates better-than-expected profitability, which likely contributed to the 4.07% increase in stock price. Investors may view this as a positive sign of the company's financial health, even though revenue details were not disclosed. The management's focus on innovation suggests potential for future growth, which could further support the stock's upward momentum.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q1-2025_